PREECLAMPSIA OF PREVENTION IN PATIENTS THROUGH ovodonation aspirin in early gestation

Instituto de Investigación Sanitaria La Fe0 个研究点目标入组 136 人开始时间: 2012年9月14日最近更新: 2018年11月6日

试验速览

暂无简介。

•Patients over 18 years. - Patients receiving oocyte donation. - Patients who have
•become pregnant. - Single or multiple gestations. - To accept the conditions of the
•study by signing the appropriate informed consent
•single pregnancies
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 372
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Known allergy to ASA. - History of peptic ulcer. - Use of prostaglandin inhibitors
•within 10 days before the start of the study. - History of chronic renal disease,
•thyroid, liver or heart disease. - Psychiatric or cognitive pathology that prevents the
•understanding of the conditions of informed consentKnown allergy to ASA. - History of peptic ulcer. - Use of prostaglandin inhibitors
•within 10 days before the start of the study. - History of chronic renal disease,
•thyroid, liver or heart disease. - Psychiatric or cognitive pathology that prevents the
•understanding of the conditions of informed consent

发起方

Instituto de Investigación Sanitaria La Fe